Readystate Asset Management LP Makes New Investment in Senseonics Holdings, Inc. Common Stock $SENS

Readystate Asset Management LP purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 101,000 shares of the company’s stock, valued at approximately $574,000. Readystate Asset Management LP owned approximately 0.24% of Senseonics Holdings, Inc. Common Stock at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Penn Capital Management Company LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at about $535,000. Stonepine Capital Management LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $276,502. Jefferies Financial Group Inc. bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $102,000. Bank of America Corp DE bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $2,241,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter worth approximately $65,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

Senseonics Holdings, Inc. Common Stock Price Performance

Senseonics Holdings, Inc. Common Stock stock opened at $9.63 on Tuesday. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $11.58. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The firm has a 50-day moving average price of $6.80 and a 200-day moving average price of $6.68. The firm has a market capitalization of $402.53 million, a PE ratio of -4.32 and a beta of 1.08.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The business had revenue of $14.48 million during the quarter. As a group, equities research analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Mizuho dropped their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 12th. Stifel Nicolaus cut their target price on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Finally, HC Wainwright reduced their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a report on Tuesday, May 12th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Senseonics Holdings, Inc. Common Stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.20.

Insider Buying and Selling

In related news, Director Douglas Roeder bought 13,953 shares of the company’s stock in a transaction on Wednesday, August 19th. The shares were acquired at an average price of $8.98 per share, with a total value of $125,297.94. Following the transaction, the director owned 171,191 shares of the company’s stock, valued at $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 4.70% of the stock is owned by company insiders.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.